Two Cases of Squamous Cell Lung Carcinoma with EGFR Mutations Presenting Poor Outcomes After Osimertinib Treatment-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Two Cases of Squamous Cell Lung Carcinoma with EGFR Mutations Presenting Poor Outcomes After Osimertinib Treatment

Published:2023-02-20 Issue:1 Volume:63 Page:52-57
ISSN:0386-9628
Container-title:Haigan
language:en
Short-container-title:JJLC

Author:

Kono Kento¹,Nakashima Kazuhisa¹,Hotta Takamasa²,Tsubata Yukari¹,Iwahashi Teruaki³,Isobe Takeshi¹

Affiliation:

1. Division of Medical Oncology & Respiratory Medicine, Department of Internal Medicine, Shimane University Faculty of Medicine

2. Department of Respiratorology, Shimane Prefectural Central Hospital

3. Department of Pathology, Shimane University Faculty of Medicine

Publisher

Japan Lung Cancer Society

Subject

Pulmonary and Respiratory Medicine,Oncology

Link

https://www.jstage.jst.go.jp/article/haigan/63/1/63_52/_pdf

Reference14 articles.

1. 1. Shukuya T, Takahashi T, Kaira R, Ono A, Nakamura Y, Tsuya A, et al. Efficacy of gefitinib for non-adenocarcinoma non-small-cell lung cancer patients harboring epidermal growth factor receptor mutations: a pooled analysis of published reports. Cancer Sci. 2011; 102: 1032-1037.

2. 2. Jänne PA, Yang JC, Kim DW, Planchard D, Ohe Y, Ramalingam SS, et al. AZD9291 in EGFR inhibitor-resistant non-small-cell lung cancer. N Engl J Med. 2015; 372: 1689-1699.

3. 3. Yamaguchi F, Kato E, Wakabayashi A, Shikama Y. Effect of osimertinib treatment on lung adenocarcinoma with squamous cell transformation harboring the T790M mutation: A case report and literature review. Mol Clin Oncol. 2019; 11: 127-131.

4. 4. Izumi H, Yamasaki A, Ueda Y, Sumikawa T, Maeta H, Nakamoto S, et al. Squamous cell carcinoma transformation from EGFR-mutated lung adenocarcinoma: a case report and literature review. Clin Lung Cancer. 2018; 19: e63-e66.

5. 5. Kong M, Sung JY, Lee SH. Osimertinib for secondary T790M-mutation-positive squamous cell carcinoma transformation after afatinib failure. J Thorac Oncol. 2018; 13: e252-e254.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of osimertinib for lung squamous cell carcinoma with de novo EGFR T790M‐positive: Case report and literature review;Thoracic Cancer;2023-08-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3